Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Multicenter, randomized, open label study evaluating a poly(ADP-ribose) polymerase-1(PARP-1) inhibitor, SAR240550 (BSI-201), administered twice weekly or weekly, in combination with gemcitabine/carboplatin, in patients with metastatic Triple Negative Breast Cancer (mTNBC)</ https://www.kusajili.fr:443/Trial/mXf5jAMx3EiGasu30VG9YA%24multicenter-randomized-open-label-study-evaluating-a-polyadp-ribose-polymerase-1parp-1-inhibitor-sar240550-bsi-201-administered
I have read and accept the terms of use of the site and the Privacy Policy
Send your message